Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Can Modicare Reshape India’s Health Care Paradigm?

Executive Summary

India’s new government-funded health care program expects to expand access to treatment to more than 100 million families. Can it effectively deliver on its promise and also materially expand opportunities for hospitals and pharma?

You may also be interested in...



It Takes A Village: Roche’s India Rare Disease Approach, Crowdfunding Support

Roche Pharma India CEO and managing director, V Simpson Emmanuel, outlines the company's multi-forked approach, including collaborating with a crowdfunding platform, to move the access and treatment needle for Evrysdi in India. The Swiss firm, along with industry associations, also suggests the need for a formal accelerated regulatory pathway in India for rare diseases.

India Budget Focuses On Huge Health Insurance Scheme Ahead Of Elections

India’s government has hiked healthcare spending in its new budget by 13.5% ahead of national elections, earmarking the lion’s share for its flagship new health insurance scheme for the nation’s poorest half-billion people. But outlays for the stretched core public health-delivery system have stagnated.

Revolving Door: Novartis India Managing Director Quits

Novartis India’s managing director has quit - the second time in 2018 that the Swiss multinational finds the corner office vacated.

Topics

Related Companies

UsernamePublicRestriction

Register

SC124237

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel